ORIGINAL RESEARCH
Accepted on 20 Oct 2025
Low-dose glucocorticoid improves progression-free survival of children with B cell acute lymphoblastic leukaemia following chimeric antigen receptor T-cell therapy
doi 10.3389/fimmu.2025.1604866
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Exploring T Cell Driven Immunotherapies: From CAR T and TILs to T Cell Engagers
Exploring T Cell Driven Immunotherapies: From CAR T and TILs to T Cell Engagers
2,218
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 16 Oct 2025
Multiplex engineering and multifunction T cells for precise and effective immunotherapies
doi 10.3389/fimmu.2025.1680410
- 493 views
REVIEW
Accepted on 09 Oct 2025
Reprogramming the tumor microenvironment to boost adoptive T cell therapy
doi 10.3389/fimmu.2025.1677548
- 269 views
REVIEW
Accepted on 06 Oct 2025
Non-signalling but all important: how the linker, hinge, and transmembrane domains in the CAR hold it all together
doi 10.3389/fimmu.2025.1664403
- 102 views
ORIGINAL RESEARCH
Published on 30 Jul 2025
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
doi 10.3389/fimmu.2025.1618404
- 1,801 views
- 1 citation
REVIEW
Published on 06 May 2025
Engaging T cells for cleanup
doi 10.3389/fimmu.2025.1551424
- 5,205 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: